Latest ebit for HCARW: $12M, above the sector sector average of $-77M.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022
As of the most recent data (September 2022), HCARW shows a EBIT of $12M. That compares with $-4M in the prior-year period — up 394.5% year over year. That is above the sector sector average of $-77M. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, HCARW's EBIT is now $12M (was $-4M) — a 394.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Healthcare Services Acquisition - Warrants (18/11/2025) is outperforming or lagging.
The its sector sector average EBIT is about $-77M. Healthcare Services Acquisition - Warrants (18/11/2025) is at $12M, which is higher that average. That is roughly 115.5% above the sector mean. Use the comparison chart on this page to see how HCARW stacks up against individual peers as well.
Tracking HCARW's ebit over time shows whether Healthcare Services Acquisition - Warrants (18/11/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $12M That compares with $-4M in the prior-year period — up 394.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Healthcare Services Acquisition - Warrants (18/11/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $12M) with ownership activity and broader fundamentals.